| Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma LD Locati, MS Serafini, MF Iannò, A Carenzo, E Orlandi, C Resteghini, ... Cancers 11 (8), 1057, 2019 | 41 | 2019 |
| Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures MS Serafini, L Lopez-Perez, G Fico, L Licitra, L De Cecco, C Resteghini Cancers of the head & neck 5, 1-10, 2020 | 35 | 2020 |
| Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project S Cavalieri, L De Cecco, RH Brakenhoff, MS Serafini, S Canevari, S Rossi, ... Head & neck 43 (2), 601-612, 2021 | 29 | 2021 |
| Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification PYF Zeng, MJ Cecchini, JW Barrett, M Shammas-Toma, L De Cecco, ... EBioMedicine 86, 2022 | 19 | 2022 |
| A functional gene expression analysis in epithelial sinonasal cancer: biology and clinical relevance behind three histological subtypes L De Cecco, MS Serafini, C Facco, R Granata, E Orlandi, C Fallai, L Licitra, ... Oral Oncology 90, 94-101, 2019 | 18 | 2019 |
| Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma S Alfieri, A Carenzo, F Platini, MS Serafini, F Perrone, D Galbiati, ... Cancers 12 (4), 922, 2020 | 16 | 2020 |
| Gene expression clustering and selected head and neck cancer gene signatures highlight risk probability differences in oral premalignant lesions A Carenzo, MS Serafini, E Roca, A Paderno, D Mattavelli, C Romani, ... Cells 9 (8), 1828, 2020 | 15 | 2020 |
| Clinical validity of a prognostic gene expression cluster-based model in human papillomavirus–positive oropharyngeal carcinoma S Cavalieri, MS Serafini, A Carenzo, S Canevari, RH Brakenhoff, ... JCO precision oncology 5, 1666-1676, 2021 | 14 | 2021 |
| hacksig: a unified and tidy R framework to easily compute gene expression signature scores A Carenzo, F Pistore, MS Serafini, D Lenoci, AG Licata, L De Cecco Bioinformatics 38 (10), 2940-2942, 2022 | 9 | 2022 |
| Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer LS Munoz-Arcos, E Nicolò, MS Serafini, L Gerratana, C Reduzzi, ... International Review of Cell and Molecular Biology 381, 1-21, 2023 | 7 | 2023 |
| Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial C Gurizzan, L Lorini, A Paderno, M Tomasoni, G Zigliani, A Bozzola, ... BMC cancer 21, 1-6, 2021 | 7 | 2021 |
| Complete response to nivolumab in recurrent/metastatic HPV-positive head and neck squamous cell carcinoma patient after progressive multifocal leukoencephalopathy: a case report LD Locati, MS Serafini, A Carenzo, S Canevari, F Perrone, E Orlandi, ... Frontiers in Oncology 11, 799453, 2022 | 6 | 2022 |
| Cellular residual disease (CRD) in early breast cancer–Expanding the concept of minimal residual disease monitoring? MS Serafini, E Molteni, E Nicolò, L Gerratana, C Reduzzi, M Cristofanilli The Journal of Liquid Biopsy 3, 100132, 2024 | 5 | 2024 |
| Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer E Nicolò, C Gianni, L Pontolillo, MS Serafini, LS Munoz-Arcos, ... Translational Breast Cancer Research 5, 2024 | 5 | 2024 |
| Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications E Nicolò, MS Serafini, L Munoz-Arcos, L Pontolillo, E Molteni, N Bayou, ... The Journal of Liquid Biopsy 2, 100117, 2023 | 4 | 2023 |
| Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab MS Serafini, S Cavalieri, L Licitra, F Pistore, D Lenoci, S Canevari, ... Journal for Immunotherapy of Cancer 12 (1), 2024 | 3 | 2024 |
| Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials D Lenoci, A Carenzo, S Cavalieri, F Pistore, MS Serafini, P Bossi, ... Oral oncology 126, 105756, 2022 | 3 | 2022 |
| BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure. F Platini, E Ortolan, S Cavalieri, G Massa, DM Filippini, S Alfieri, ... Journal of Clinical Oncology 38 (15_suppl), e18577-e18577, 2020 | 3 | 2020 |
| Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients J Iacovacci, MS Serafini, B Avuzzi, F Badenchini, A Cicchetti, A Devecchi, ... EBioMedicine 106, 2024 | 2 | 2024 |
| Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities D Lenoci, C Resteghini, MS Serafini, F Pistore, S Canevari, B Ma, ... Translational Research 265, 1-16, 2024 | 2 | 2024 |
